Weill Cornell Medicine
His primary areas of study are Microbiology, Drug resistance, Imipenem, Klebsiella and Acinetobacter baumannii. His Microbiology study frequently links to related topics such as DNA gyrase. His Drug resistance study combines topics in areas such as Klebsiella pneumoniae and Enterobacteriaceae.
His research investigates the link between Imipenem and topics such as Polymyxin B that cross with problems in Amikacin, Polymyxin, Rifampicin and Neisseriaceae. His Klebsiella study incorporates themes from Antibacterial agent, Infection control, Cephalosporin Resistance, Cephalosporin Antibiotic and Carbapenem. His Antibiotic resistance research incorporates elements of Molecular epidemiology and Escherichia coli.
Microbiology, Antibiotics, Klebsiella pneumoniae, Acinetobacter baumannii and Antibiotic resistance are his primary areas of study. The various areas that he examines in his Microbiology study include Virology and Enterobacteriaceae, Escherichia coli. His Antibiotics research is multidisciplinary, incorporating elements of Plasmid and Beta-lactamase.
His study looks at the intersection of Klebsiella pneumoniae and topics like Klebsiella with Cephalosporin. His Acinetobacter baumannii study which covers Polymyxin B that intersects with Polymyxin and Imipenem. His Antibiotic resistance research integrates issues from Antimicrobial and Intensive care medicine.
Carl Urban mainly focuses on Microbiology, Klebsiella pneumoniae, Escherichia coli, Antibiotics and Drug resistance. His work deals with themes such as Enterobacteriaceae and Acinetobacter baumannii, which intersect with Microbiology. His research integrates issues of Gerontology, Carbapenem and Virology in his study of Klebsiella pneumoniae.
The concepts of his Escherichia coli study are interwoven with issues in Urine and Beta. The Antibiotics study combines topics in areas such as Internal medicine, Methicillin-resistant Staphylococcus aureus and Daptomycin. His biological study spans a wide range of topics, including Traditional medicine, MEDLINE and Antibiogram.
Carl Urban spends much of his time researching Microbiology, Drug resistance, Escherichia coli, Antibiotic resistance and Klebsiella pneumoniae. Multiple drug resistance and Antibiotics are among the areas of Microbiology where Carl Urban concentrates his study. Drug resistance is closely attributed to Antimicrobial in his work.
His Escherichia coli research includes elements of Molecular epidemiology and Pulsed-field gel electrophoresis. Carl Urban has researched Antibiotic resistance in several fields, including Internal medicine and Epidemiology. His Klebsiella pneumoniae research incorporates themes from Enterobacteriaceae, Acinetobacter baumannii and Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella
James J. Rahal;Carl Urban;David Horn;Katherine Freeman.
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Kenneth S. Meyer;Carl Urban;Janet A. Eagan;Barbara J. Berger.
Annals of Internal Medicine (1993)
Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City
Patricia A. Bradford;Simona Bratu;Carl Urban;Melissa Visalli.
Clinical Infectious Diseases (2004)
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam
E.S Go;C Urban;J Burns;N Mariano.
The Lancet (1994)
Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
Carl Urban;Sorana Segal-Maurer;James J. Rahal.
Clinical Infectious Diseases (2003)
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
James R Johnson;Veronika Tchesnokova;Brian D Johnston;Connie Clabots.
The Journal of Infectious Diseases (2013)
Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus.
H de Lencastre;A M Sá Figueiredo;C Urban;J Rahal.
Antimicrobial Agents and Chemotherapy (1991)
In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
Jimmy Yoon;Carl Urban;Christian Terzian;Noriel Mariano.
Antimicrobial Agents and Chemotherapy (2004)
Effect of Sulbactam on Infections Caused by Imipenem-Resistant Acinetobacter calcoaceticus Biotype anitratus
Carl Urban;Eddie Go;Noriel Mariano;Barbara J. Berger.
The Journal of Infectious Diseases (1993)
Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program
D. A. Figueroa;E. Mangini;M. Amodio-Groton;B. Vardianos.
Clinical Infectious Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: